HOME >> BIOLOGY >> NEWS
Blood test for colon cancer risk to be goal of Hopkins project

An interdisciplinary team of scientists from Johns Hopkins and elsewhere has been selected to receive a $2.25 million, five-year grant from the Doris Duke Charitable Foundation to develop a practical test to predict a person's risk of colon cancer by looking for a particular biological marker in the blood.

If successful, the test could be broadly applied to identify those who most need to be monitored with invasive but standard colonoscopy or who should make changes in their diet or in other factors to help lower their risk of developing colon cancer.

The researchers' test is based on the fact that five percent to 10 percent of people have improper control of a growth-promoting gene called insulin-like growth factor 2 or IGF-2. The Johns Hopkins scientists reported in February that, in mice, the double dose of IGF-2 protein sets the stage for cancer development -- by increasing the number of primitive cells found in the colon -- and that early evidence suggests the same could be true in people.

"If everything works out -- if IGF-2 status is tied to colon cancer risk in people and the blood test is workable -- then IGF-2 status could be the colon cancer equivalent of cholesterol levels as a risk factor for heart disease," says Andrew Feinberg, M.D., Ph.D., professor of medicine at Johns Hopkins and one of the leaders of the project. "We've never had a broad molecular screening tool like that for any cancer."

But there's a lot of work to do first. With the new Doris Duke Charitable Foundation grant, part of the foundation's Clinical Interfaces Award Program, Feinberg and his colleagues will develop and validate the blood test, study how IGF-2 status changes over time and evaluate whether IGF-2 status is a predictor of colon cancer. Patients will be enrolled at Johns Hopkins Hospital and at the Cleveland Clinic Foundation in Ft. Lauderdale, Fla.

"We've long suspected that genomic changes underlie cancer risk, but that knowledg
'"/>

Contact: Joanna Downer
jdowner1@jhmi.edu
410-614-5105
Johns Hopkins Medical Institutions
9-Sep-2005


Page: 1 2 3

Related biology news :

1. Blood test may help signal tumors remission, return in throat cancer patients
2. Blood sugars manufacture limited by building blocks supply
3. Bloods clotting cells harbor ticking time bombs, finding may help extend blood supply
4. Blood tests may be possible for mental health conditions
5. Cord Blood Registry achieves industry-leading stem cell recovery with new automation technology
6. Blood test predicts cardiac events and death in heart patients
7. Blood clot fibers more elastic than spiders web
8. Blood-compatible nanoscale materials possible using heparin
9. Blood pressure medication may revolutionize treatment of Marfan syndrome
10. Blood levels of suspected carcinogen vary by race, ethnicity
11. Blood conservation strategies take center stage at Emory University Hospital forum

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/21/2019)... ... ... Dr. David Greene , Founder and CEO of R3 Stem Cell, ... the Rescue, was produced by Award Winning filmmaker Dr. Elliott Haimoff. , In the ... safety of the procedures along with the potential for helping patients avoid potentially risky ...
(Date:5/21/2019)... , ... May 21, 2019 , ... At their May ... for Tissue Engineered Medical Products (TEMPs) of the American Society for Testing and ... . Gaining this approval was the next step in the company’s plan to ...
(Date:5/15/2019)... ... 15, 2019 , ... The conventional method for characterizing brain ... ultra-thin two-dimensional slices, placed on glass microscope slides and qualitatively evaluated after staining. ... the brain is a highly heterogenous and complex tissue that is challenging to ...
Breaking Biology News(10 mins):
(Date:4/18/2019)... ... 2019 , ... Taking a step closer to a “green” ... Worcester Polytechnic Institute (WPI) has developed a novel process using an unusual solvent ... other biofuels more economically. , Isobutanol, like ethanol, is an alcohol, but its ...
(Date:4/10/2019)... ... April 10, 2019 , ... ... have locked into multiple agreements to help companies advance their innovations to ... industry, ranging from synthetic biology companies that are gene editing therapeutic cells ...
(Date:4/8/2019)... JORDAN, Utah and BOSTON (PRWEB) , ... April ... ... in delivering cloud-based enterprise-class unified communications and collaboration solutions, announced today the launch ... provides integration to an unprecedented range of business and contact-orientated applications while using ...
(Date:3/29/2019)... ... March 28, 2019 , ... ... milestones, CARB-X has proceeded with a second stage of funding for Specific’s Reveal™ ... which is on top of the $1.7 million already awarded by CARB-X. The ...
Breaking Biology Technology:
Cached News: